ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,844Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 26

$707K Total Retail Price of All Prescriptions

Rank: 1 out of 26

317 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 317 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.

Schedule Three
Controlled Substances

8% of this provider’s 317 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 8,545 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 415 363 1 1
LISINOPRIL 360 289 2 2
SIMVASTATIN 334 273 3 6
METOPROLOL TARTRATE 332 303 4 4
LEVOTHYROXINE SODIUM 301 245 5 3
FUROSEMIDE 274 235 6 5
MIRTAZAPINE 252 249 7 9
TRAZODONE HCL 243 210 8 14
GABAPENTIN 210 160 9 12
TRAMADOL HCL 207 184 10 13
METFORMIN HCL 207 130 10 18
DIVALPROEX SODIUM 191 129 12 33
WARFARIN SODIUM 186 156 13 7
DONEPEZIL HCL 181 181 14 11
NAMENDA 163 163 15 25
CITALOPRAM HBR 157 123 16 10
LACTULOSE 138 123 17 42
EXELON 130 130 18 76
RANITIDINE HCL 127 102 19 30
OMEPRAZOLE 126 92 20 8
RISPERIDONE 124 103 21 19
HYDROCODONE-ACETAMINOPHEN 113 82 S3 22 21
ESCITALOPRAM OXALATE 112 101 23 47
METOPROLOL SUCCINATE 100 88 24 22
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 73 25 60
FENTANYL 95 57 S2 25 38
SERTRALINE HCL 90 89 27 15
LANTUS 89 64 28 28
HUMALOG 87 64 29 91
DIOVAN 86 75 30 62
ATORVASTATIN CALCIUM 86 63 30 16
SPIRIVA 81 61 32 53
CLOPIDOGREL 79 49 33 36
IPRATROPIUM-ALBUTEROL 78 62 34 95
SPIRONOLACTONE 77 77 35 96
HYDRALAZINE HCL 77 45 35 65
KLOR-CON M20 72 68 37 49
LOSARTAN POTASSIUM 72 72 37 39
ADVAIR DISKUS 71 62 39 52
FLUOXETINE HCL 68 13 40 79
LEVEMIR 67 50 41 102
ATENOLOL 65 64 42 26
ZOLPIDEM TARTRATE 64 35 43 37
PANTOPRAZOLE SODIUM 63 48 44 23
CARVEDILOL 62 49 45 41
LEVOFLOXACIN 60 51 46 58
LEVETIRACETAM 58 41 47 29
HYDROCHLOROTHIAZIDE 58 53 47 20
FAMOTIDINE 56 40 49 60
JANTOVEN 55 46 50 43
FLUTICASONE PROPIONATE 55 26 50 71
LATANOPROST 55 55 50 115
CLONIDINE HCL 53 36 53 69
CYMBALTA 53 40 53 45
NITROGLYCERIN PATCH 52 49 55 86
QUETIAPINE FUMARATE 51 47 56 27
PRAVASTATIN SODIUM 51 45 56 17
BRIMONIDINE TARTRATE 51 42 56 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.